Differin® Expands Portfolio with the Addition of Two New Facial Skincare Products
Leading Acne-Fighting Brand Continues to Address Consumers’ Needs with Complete Regimen of Innovative Skincare Solutions
Fort Worth, TX (February 21, 2018) – Nestlé Skin Health and its medical solutions business, Galderma, are excited to announce the introduction of Differin Daily Deep Cleanser and Differin Oil Control Moisturizer with SPF 30 as the latest additions to the Differin portfolio of innovative acne solutions.
Differin Daily Deep Cleanser will deliver the efficacy of maximum-strength benzoyl peroxide, but with less irritation and redness. The sensitive skin formula is ideal for those seeking a deep, powerful cleansing that won’t strip their delicate skin. Differin Oil Control Moisturizer with SPF 30, on the other hand, is an oil-free, lightweight moisturizer that is compatible for use with Differin Gel as part of your daily skincare routine.
Last year, Differin made a splash into the acne category with the OTC launch of Differin Gel (0.1% adapalene). This milestone marked the newest advancement in the OTC acne category in more than 30 years. During its first year at shelf, Differin Gel received ten coveted beauty awards from nationally-acclaimed magazines and digital properties – including the sought-after 2017 Allure Best of Beauty Award – making it the most-awarded acne treatment of 2017.
“Making the power of Differin Gel available to consumers without a prescription was our first step in helping the millions of acne sufferers nationwide,” says June Risser, Vice President and General Manager, Consumer Business at Nestlé Skin Health. “The introduction of our new Differin Daily Deep Cleanser and Oil Control Moisturizer with SPF 30 underscores our continued commitment to delivering efficacious skincare solutions that are both affordable and accessible to consumers.”
Differin Daily Deep Cleanser and Differin Oil Control Moisturizer with SPF 30 will be available for a suggested retail price of $8.99 at major retailers nationwide and online beginning this month.
Differin®, the leading acne franchise within Galderma, Nestlé Skin Health’s medical solutions business, was the first brand to receive FDA approval to make the power of prescription-strength, acne-fighting retinoids available over-the-counter, marking the newest ingredient in the OTC acne category in more than 30 years. Differin® Gel contains adapalene, a safe and effective retinoid, which doctors have prescribed to more than 40 million people globally for more than 20 years.
With a commitment to providing effective acne solutions, Differin’s portfolio also includes products to support a healthy skincare routine, including cleansers and moisturizers.
For more information, please visit www.differin.com.
About Nestlé Skin Health
Nestlé Skin Health’s mission is to enhance quality of life by delivering science-based solutions for the health of skin, hair and nails. As one of the category’s leading companies, Nestlé Skin Health conducts groundbreaking product research to provide both the healthcare community and the consumer with an ongoing progression of innovative technologies and products to protect, serve and enhance skin health.
For more information, please visit www.nestleskinhealth.com.
Galderma, Nestlé Skin Health’s medical solutions business, was created in 1981 and is now present in over 100 countries with an extensive product portfolio to treat a range of dermatological conditions. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin, hair and nails.
Galderma North America